EXPRESS: Treatment of non-effusive feline infectious peritonitis using oral remdesivir or GS-441524: a randomized, double-blind noninferiority trial.

Key Points

• This research aims to evaluate the effectiveness of remdesivir compared to GS-441524 in treating non-effusive feline infectious peritonitis (FIP).
• Conducted a randomized, double-blind trial to compare treatments.
• Included cats previously treated for non-effusive FIP.
• Focused on measuring relapse rates and management strategies.
• Both remdesivir and GS-441524 showed effectiveness as treatment options.
• Further analysis is needed to understand relapse management.